HealthEquity Price to Book Ratio 2014-2024 | HQY

Historical price to book ratio values for HealthEquity (HQY) over the last 10 years. The current price to book ratio for HealthEquity as of November 20, 2024 is 4.16.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

HealthEquity Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-11-19 102.67 4.16
2024-07-31 78.48 $24.70 3.18
2024-04-30 78.91 $24.11 3.27
2024-01-31 75.58 $23.63 3.20
2023-10-31 71.68 $23.17 3.09
2023-07-31 67.94 $22.77 2.98
2023-04-30 53.45 $22.45 2.38
2023-01-31 60.85 $22.37 2.72
2022-10-31 77.91 $22.25 3.50
2022-07-31 58.17 $22.06 2.64
2022-04-30 62.32 $21.99 2.83
2022-01-31 53.44 $22.11 2.42
2021-10-31 66.18 $22.39 2.96
2021-07-31 73.98 $22.28 3.32
2021-04-30 75.97 $22.17 3.43
2021-01-31 83.55 $17.87 4.68
2020-10-31 51.49 $17.61 2.92
2020-07-31 51.56 $17.44 2.96
2020-04-30 56.27 $14.58 3.86
2020-01-31 66.06 $14.50 4.56
2019-10-31 56.79 $14.37 3.95
2019-07-31 81.98 $14.40 5.69
2019-04-30 67.75 $8.44 8.03
2019-01-31 62.34 $7.64 8.16
2018-10-31 91.80 $7.32 12.54
2018-07-31 75.50 $6.95 10.86
2018-04-30 65.67 $6.42 10.22
2018-01-31 50.62 $5.69 8.89
2017-10-31 50.22 $5.51 9.11
2017-07-31 45.87 $5.23 8.77
2017-04-30 45.52 $4.86 9.38
2017-01-31 46.25 $4.40 10.51
2016-10-31 33.23 $4.26 7.80
2016-07-31 29.52 $4.09 7.21
2016-04-30 25.15 $3.84 6.54
2016-01-31 21.55 $3.52 6.11
2015-10-31 32.71 $3.47 9.43
2015-07-31 33.66 $3.34 10.07
2015-04-30 26.21 $2.79 9.38
2015-01-31 20.77 $2.63 7.90
2014-10-31 20.40 $2.57 7.95
2014-07-31 17.60 $0.91 19.34
Sector Industry Market Cap Revenue
Medical Medical Services $8.966B $1.000B
HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
Charles River Laboratories (CRL) United States $9.516B 18.39
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00